There are 398 resources available
Invited Discussant 58O
Presenter: Barbara Pistilli
Session: Proffered Paper session 2
Resources:
Slides
Webcast
LBA1 - Unraveling the mechanism of action and resistance to Trastuzumab deruxtecan (T-DXd): biomarker analyses from patients from DAISY trial
Presenter: Maria Fernanda Mosele
Session: Proffered Paper session 2
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA1
Presenter: Peter A. Fasching
Session: Proffered Paper session 2
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Proffered Paper session 2
Resources:
Webcast
Is HER2 low breast cancer a real entity?
Presenter: Frédérique Penault-Llorca
Session: Treating HER2 low metastatic breast cancer
Resources:
Slides
Webcast
Oral SERDs: Coming soon but to what end?
Presenter: Ana Mafalda Antunes De Melo e Oliveira
Session: Emerging new drugs and strategies for breast cancer
Resources:
Slides
Webcast
Targeting the PIK/AKT/mTOR pathway: Making sense of the relationships
Presenter: Rebecca Dent
Session: Emerging new drugs and strategies for breast cancer
Resources:
Slides
Webcast
New horizons for HER2 low breast cancer treatments (incl. combination therapy, vaccine therapy)
Presenter: Elizabeth Mittendorf
Session: Treating HER2 low metastatic breast cancer
Resources:
Slides
Webcast
Targeting metabolism: Changing breast cancer’s diet
Presenter: Valter Longo
Session: Emerging new drugs and strategies for breast cancer
Resources:
Slides
Webcast
How to treat HER2 low breast cancer on Monday?
Presenter: Joohyuk Sohn
Session: Treating HER2 low metastatic breast cancer
Resources:
Slides
Webcast